SS 31 (Elamipretide) Peptide, US Made & High Quality
Learn more ► Buy Elamipretide
#ss_31 #ss31 ss_31_review #ss_31_peptide
SS-31, also known as Elamipretide, is a small peptide that targets cell and mitochondrial membrane.
Cardiolipin makes up the inner mitochondrial membrane, in which its function includes being part of the electron transport chain.
SS-31 drug is the first peptide to undergo clinical trials as a possible treatment for this disorder.
Clinical studies indicate that elamipretide peptide increases mitochondrial respiration and enhances electron transport chain function, resulting in improved mitochondrial function.
Scientists are thoroughly investigating the effects of elamipretide in treating primary mitochondrial diseases like cardiomyopathy, Leber’s hereditary optic neuropathy, and Barth Syndrome.
In phase 1, Stealth conducted a trial evaluating SS 31 safety, tolerability, and effectiveness in treating mitochondrial myopathy.
Results showed that elamipretide treatment improved patients’ exercise capacity and mitochondrial functioning.
In phase 2, researchers examined mitochondrial disease patients who participated in the trial to evaluate their results and the safety of elamipretide.
In elamipretide phase 3, researchers evaluated daily ss-31 injections for their safety and ability to treat the disorder.
Primary mitochondrial diseases (PMDs) are caused by dysfunction in the energy-creating apparatus of mitochondria.